Skip Navigation

CostCheck™ Quarterly: Q3, 2022

CostCheck™ Quarterly: Q3, 2022

BluesightⓇ is sharing data from its CostCheck product on a quarterly basis to show where and how its customers are saving money. CostCheck ingests real-time drug pricing and purchasing data to drive analytics that optimize product selection,GPO compliance, 340B optimization and contract price parity.

In Q3 alone, CostCheck saved its customers over $7 million , and has saved customers over $20 million dollars through 2022 YTD.

Download the latest information about our suite of medication intelligence products by using the button below.

Want to read the rest?